Literature DB >> 16154322

Epilepsy and quality of life in adults: a review of instruments.

Maurizio A Leone1, Ettore Beghi, Claudia Righini, Giovanni Apolone, Paola Mosconi.   

Abstract

The aim of this report is to describe the state of the art of quality of life (QoL) instruments used for adults with epilepsy and to help those in the field to identify, select, and use the instruments most suitable for their purposes. We searched Medline and the Cochrane Database for articles in English, German, French, Spanish, Portuguese and Italian published by the end of 2002. Electronic retrieval was completed by hand-search. The final list included 203 articles reporting 205 studies. There were 62 validation studies and 143 clinical studies, including 7 population studies, 45 "pure" observational, 37 observational with aspects of validation and 54 experimental (38 randomized clinical trials and 16 non-randomized or non-controlled trials). Twenty-four generic and 21 specific QoL instruments were used. Eight were used in more than 10 studies, while 21 were used only once; 7/24 generic and 19/21 specific questionnaires were validated for epilepsy. The different domains considered in the 26 questionnaires specifically validated for epilepsy are listed. We classified questionnaires according to three aspects: validation, diffusion of use, and specificity of domains. Questionnaires covering all three aspects (WPSI, ESI-55, QOLIE-89, QOLIE-31, QOLIE-10, Liverpool Batteries) should be preferred when planning a QoL study in epilepsy. However, those covering only two aspects (SF-36, SEALS, EPSES, EOS, PESOS, QOLAS) could also be useful in selected situations or may become a first-choice instrument in the future, after more widespread use or complete validation. All the other instruments should at present be considered only for second choice.

Entities:  

Mesh:

Year:  2005        PMID: 16154322     DOI: 10.1016/j.eplepsyres.2005.02.009

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

1.  The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.

Authors:  Erik K St Louis
Journal:  Pharmaceuticals (Basel)       Date:  2010-09-01

Review 2.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

3.  Neuro-QOL and the NIH Toolbox: implications for epilepsy.

Authors:  Cindy J Nowinski; David Victorson; Jose E Cavazos; Richard Gershon; David Cella
Journal:  Therapy       Date:  2010-09-01

4.  Disease-targeted versus generic measurement of health-related quality of life in epilepsy.

Authors:  Christine B Baca; Barbara G Vickrey; Stefanie Vassar; Anne T Berg
Journal:  Qual Life Res       Date:  2014-11-21       Impact factor: 4.147

5.  Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece.

Authors:  Charitomeni Piperidou; Anna Karlovasitou; Nikolaos Triantafyllou; Evagelia Dimitrakoudi; Aikaterini Terzoudi; Eleni Mavraki; Grigorios Trypsianis; Konstantinos Vadikolias; Ioannis Heliopoulos; Dimitrios Vassilopoulos; Stavros Balogiannis
Journal:  Qual Life Res       Date:  2008-07-29       Impact factor: 4.147

6.  Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Authors:  D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

7.  Feasibility of the collection of patient-reported outcomes in an ambulatory neurology clinic.

Authors:  Lidia M V R Moura; Eli Schwamm; Valdery Moura Junior; Michael P Seitz; John Hsu; Andrew J Cole; Lee H Schwamm
Journal:  Neurology       Date:  2016-11-04       Impact factor: 9.910

Review 8.  The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.

Authors:  Erik K. St. Louis
Journal:  Pharmaceuticals (Basel)       Date:  2010-09-06

9.  Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care.

Authors:  Erik K St Louis; Erik K Louis
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

Review 10.  Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements.

Authors:  Annabel Nixon; Cicely Kerr; Katie Breheny; Diane Wild
Journal:  Health Qual Life Outcomes       Date:  2013-03-11       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.